Incidence of ALS in all 50 states in the United States, data from the National ALS Registry, 2012–2019

Заболеваемость боковым амиотрофическим склерозом во всех 50 штатах США: данные Национального регистра БАС, 2012–2019 гг.
D. Kevin Horton, Paul Mehta, Jaime S. Raymond, Theodore C. Larson III, Reshma Punjani, Theresa Nair, Moon Han, Suraya Mohidul, Jasmine Berry, Song Xue
2025-06-01

National ALS Registryadministrative databasesage-adjusted incidence ratesamyotrophic lateral sclerosisstate-level incidence
OBJECTIVE: To summarize amyotrophic lateral sclerosis (ALS) incidence in all 50 states and the District of Columbia from 2012 to 2019. In 2010, the Agency for Toxic Substances and Disease Registry (ATSDR) launched the congressionally mandated National ALS Registry (Registry) to determine the incidence and prevalence of ALS within the United States, characterize demographics, and identify potential risk factors. This is the first analysis of state-level ALS incidence estimates for all 50 states and the District of Columbia. METHODS: ALS is not a notifiable disease in the United States. As such, the Registry identifies cases using existing national administrative databases (Medicare, Veterans Health Administration, and Veterans Benefits Administration), and a secure web portal that identifies cases not included in the national databases. Confirmed and likely cases are deduplicated and counted as incident cases for the first year they are identified using a validated algorithm. Incident counts, incident rates, and rate ratios were then calculated. RESULTS: State-level age-adjusted overall incidence rates for 2012 to 2019 ranged from 0.65 per 100,000 persons (Alaska) to 2.25 per 100,000 persons (Vermont), with an overall incidence of 1.44 per 100,000 persons in the United States. New England and the upper Midwest regions had higher incidence rates than national rates. CONCLUSIONS: These findings summarize the incidence of ALS for all 50 states from 2012 to 2019. This is a continuing effort to identify ALS cases nationally. The establishment of the Registry allows for epidemiological analyses of ALS data and the assessment of potential risk factors.
1
Age-adjusted ALS incidence ranged from 0.65 per 100,000 persons in Alaska to 2.25 per 100,000 in Vermont.
2
New England and the upper Midwest had higher ALS incidence rates than the national rate.
3
Overall ALS incidence in the United States was 1.44 per 100,000 persons during 2012–2019.
4
The National ALS Registry estimated state-level ALS incidence across all 50 states and the District of Columbia from 2012 to 2019.
5
The Registry integrates national administrative databases and web-based case identification to support nationwide ALS epidemiology and risk-factor assessment.

Amyotrophic lateral sclerosis (ALS) incidence across all 50 U.S. states and the District of Columbia from 2012 to 2019

State-level age-adjusted incidence rates, incident counts, and regional variation in ALS incidence

Publication Details
Publication Date
2025-06-01
Journal
Publisher
ISSN
Cited by
4
Access Type
Author Information
Authors
D. Kevin Horton
Paul Mehta
Jaime S. Raymond
Theodore C. Larson III
Reshma Punjani
Theresa Nair
Moon Han
Suraya Mohidul
Jasmine Berry
Song Xue
Explore further
Open the scid.ai AI chat with a ready-made request: it will find papers on a similar topic and help build a literature review.
Find similar papers in the chat →
Make a presentation
100%